Myriad Genetics, Inc. (MYGN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$3.20
+5.79%
Mkt Cap $270.12M
Analyst Ratings
Buy
0
Hold
5
Sell
0
Price Target (17 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+87.8%
Consensus $6.00 vs current $3.20